Jiangsu Cowin Biotech Co. Ltd. A (688426 SHG) stock market data APIs

Jiangsu CoWin Biotech Co., Ltd. engages in the research, development, sales, testing, and technology services of biological reagents in China. The company offers RT-PCR, PCR, multiplex PCR, and qPCR; collection, such as cfDNA, fecal DNA, saliva DNA, and urine DNA storage tube, as well as other collection products; cfDNA, genomic DNA, FFPE DNA extraction, and plasmid kit; molecular raw materials; quantitative analysis, RNA sequencing, adapter, purification magbeads, DNA sequencing, and single cells sequencing products; molecular cloning, such as cloning reagents; nucleic acid residue and contamination screening reagent; and other products. It also provides gene synthesis, gene fragment, and codon optimization services. The company's products and services are used in infectious disease, eugenics and good parenting, and oncology applications. The company was founded in 2007 and is headquartered in Taizhou, China.